SUNRISE TECHNOLOGIES INTERNATIONAL INC
10-Q/A, 1997-06-11
DENTAL EQUIPMENT & SUPPLIES
Previous: INTERNATIONAL STANDARDS GROUP LIMITED, 8-K, 1997-06-11
Next: REGENT BANCSHARES CORP, S-1, 1997-06-11



               SECURITIES AND EXCHANGE COMMISSION
                     WASHINGTON, D.C.  20549
                                
                           FORM 10-Q/A

(Mark One)
[X]  QUARTERLY  REPORT PURSUANT TO SECTION 13 OR 15(d)  OF  THE
     SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 1997
- - OR -
[]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)  OF  THE
     SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
                                
                Commission file number:   1-10428
                                

            SUNRISE TECHNOLOGIES INTERNATIONAL, INC.
     (Exact name of registrant as specified in its charter)


                   DELAWARE                      77-0148208
        (State or other jurisdiction          (I.R.S. Employer 
      of incorporation or organization)      Identification No.)

47257 FREMONT BOULEVARD, FREMONT, CALIFORNIA       94538
  (Address of principal executive offices)       (zip code)

Registrant's telephone number, including area code: 510-623-9001

                               N/A
 (Former name, former address and former fiscal year, if changed
                       since last report)


      Indicate by check [X] whether the registrant (1) has  filed
all  reports required to be filed by Section 13 or 15(d)  of  the
Securities  Exchange Act of 1934 during the preceding  12  months
(or  for such shorter period that the registrant was required  to
file  such  reports),  and (2) has been subject  to  such  filing
requirements  for  the past 90  days.  Yes  [X]           No   []

                                
        APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
          PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
                                
      Indicate by check [X] whether the registrant has filed  all
documents and reports required to be filed by Section 12,  13  or
15(d)  of the Securities Exchange Act of 1934 subsequent  to  the
distribution  of securities under a plan confirmed  by  a  court.
Yes  []  No  []

              APPLICABLE ONLY TO CORPORATE ISSUERS:
                                
 As of June 6, 1997, the number of shares of Common Stock of the
             Registrant outstanding was 27,886,247.

<PAGE>


                              INDEX

            SUNRISE TECHNOLOGIES INTERNATIONAL, INC.



                                                            Page
Part I.   Financial Information

     Item 1.                Financial Statements (unaudited)

       Consolidated Statements of Operations for the three
       months ended March 31, 1997 and 1996 ................  1

       Consolidated Balance Sheets as of March 31, 1997 and
       December 31, 1996 ...................................  2

       Consolidated Statements of Cash Flows for the three
       months ended
       March 31, 1997 and 1996 .............................  3

       Notes to Consolidated Financial Statements ..........  4


       Signatures ..........................................  6

<PAGE>


                Part I.     Financial Information

Item 1.   Financial Statements


           SUNRISE TECHNOLOGIES INTERNATIONAL, INC.

            Consolidated Statements of Operations
                         (unaudited)


                                          THREE MONTHS ENDED
                                              MARCH 31,
                                           1997        1996
                                        (In thousands, except
                                          per share amounts)

Net revenues ...........................  $1,009       $1,521   

Cost of revenues .......................     958        1,139    
                                          ______       ______

Gross profit ...........................      51          382     
                                                                
Other costs and expenses:                                       
  Engineering and development ..........     273          343     

  Sales, marketing and regulatory ......     659          946     

  General and administrative ...........     706          567     
                                         _______      _______

       Total other costs and expenses ..   1,638        1,856    
                                         _______      _______

Loss from operations ................... (1,587)      (1,474)  

Interest income ........................      11           34     

Interest expense, including non-cash                             
interest associated ....................   (812)          (3)
                                        ________     ________

with redeemable convertible notes
       Net loss ....................... $(2,388)     $(1,443)
                                        ========     ========
                   
Net loss per share                       $(0.09)      $(0.06)  
                                        ========     ========
  Shares used in calculation of net
  loss per share ......................   27,871       25,315   
                                        ========     ========


                     See accompanying notes.

                                1
<PAGE>


            SUNRISE TECHNOLOGIES INTERNATIONAL, INC.

                   Consolidated Balance Sheets

                                        MARCH 31,     DECEMBER
                                           1997       31, 1996
                                       (unaudited)     (Note)

                ASSETS                      (In thousands)
                                                                 
Current assets:                                                  
  Cash and cash equivalents ............. $1,618         $647     

  Accounts receivable, net of allowance .    815          472     

  Inventories ...........................  2,225        2,135    

  Prepaid expenses ......................    214          288     
                                          ______       ______

       Total current assets .............  4,872        3,542    
                                                              
Property and equipment, net .............    191          199     
                                          ______       ______

Total assets ............................ $5,063       $3,741   
                                                              
 LIABILITIES AND STOCKHOLDERS' EQUITY                         

Current liabilities:                                          
  Accounts payable ......................   $700       $1,586   

  Accrued payroll and related expenses ..    252          209     

  Accrued warranty ......................    199          199     

  Other accrued expenses ................    456          475     
                                          ______       ______

       Total current liabilities ........  1,607        2,469    
                                                               
Redeemable convertible notes ............  3,530          _     
                                                              
Commitments and contingencies ...........    _            _     
                                                              
Stockholders' equity:                                         
     Preferred Stock, $0.001 par value,                            
        2,000,000 shares authorized, none  
        issued or outstanding ...........    _            _

     Common Stock, $0.001 par value,                               
        40,000,000 shares                                    
        authorized, 27,886,247 and 
        27,868,613 shares 
        issued and outstanding at March 
        31, 1997 and December 31, 1996 
        respectively ....................      28          28

  Additional paid-in capital ............  32,730      31,688   

  Accumulated deficit ...................(32,832)    (30,444)
                                         ________    ________

    Total stockholders' equity ..........    (74)       1,272    
                                           ______      ______

Total liabilities and stockholders'         
equity ..................................  $5,063      $3,741
                                         ========    ========

NOTE:  The  consolidated balance sheet at December 31,  1996  has
been  derived from the audited financial statements at that  date
but  does  not  include  all  of the  information  and  footnotes
required by generally accepted accounting principles for complete
financial statements.

                     See accompanying notes.

                                2
<PAGE>


            SUNRISE TECHNOLOGIES INTERNATIONAL, INC.
                                
              Consolidated Statements of Cash Flows
        Increase (Decrease) in Cash and Cash Equivalents
                           (unaudited)

                                
                                          Three months ended
                                              March 31,
                                           1997         1996
                                            (In thousands)
CASH FLOWS FOR OPERATING ACTIVITIES:                          
Net Loss ............................... $(2,388)    $(1,443)

Adjustments to reconcile net loss to                          
net cash used
in operating activities:
Depreciation and amortization ..........        8          20    

Provision for doubtful accounts ........       15          _    

Non-cash interest expense ..............      812          _    

Changes in assets and liabilities:                            
Accounts receivable ....................    (358)        (198)   

Inventories ............................     (90)        (967)   
                                          
Prepaid expenses .......................       74           17    

Accounts payable .......................    (886)          421    

Accrued payroll and related expenses ...       43           29    

Other accrued expenses .................     (19)         (10)   
                                          _______      _______

Total adjustments ......................    (401)        (688)   
                                          _______      _______

Net cash used in operating activities ..  (2,789)      (2,131)  
                                          _______      _______
                                                              
CASH FLOWS FROM INVESTING ACTIVITIES:                         
Purchase of property and equipment .....     _             (5)   
                                          _______      _______

Net cash used in investing activities ..     _             (5)   
                                          _______      _______
                                                              
CASH FLOWS FROM FINANCING ACTIVITIES:                         
Issuance of common stock, net of              
offering costs .........................       17           74

Issuance of redeemable convertible                             
notes, net of insurance costs ..........    3,743          _
                                          _______      _______

Net cash provided by (used in)                
financing activities ...................    3,760           74
                                          _______      _______

NET INCREASE (DECREASE) IN CASH AND         
CASH EQUIVALENTS .......................      971      (2,062) 
                                                              
Cash and cash equivalents at beginning       
of period ..............................      647        3,514
                                          _______      _______

CASH AND CASH EQUIVALENTS AT END OF         
PERIOD .................................   $1,618       $1,452
                                          =======      =======
                                
                                
                                
                     See accompanying notes.

                                3
<PAGE>

                                
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                        (unaudited)
                                
                         March 31, 1997

1.   Basis of Presentation

   The consolidated financial statements include the accounts  of
the  Company  and its wholly-owned subsidiaries after elimination
of  all  material intercompany balances and transactions. Certain
reclassifications have been made to prior year amounts  in  order
to conform to the current presentation.

   The  consolidated financial data for the quarters ended  March
31,  1997  and  1996 are unaudited, but include  all  adjustments
(consisting  only  of  normal  recurring  adjustments)  that  the
management  of Sunrise Technologies International, Inc.  believes
to  be  necessary for fair presentation of the periods presented.
Interim results are not necessarily indicative of results for the
full   year.   The  financial  statements  should  be   read   in
conjunction  with the audited financial statements for  the  year
ended  December 31, 1996 included in the Company's annual  report
on Form 10-K filed with the Securities and Exchange Commission.

   The  Company  has  incurred significant losses  for  the  last
several years and at March 31, 1997 has an accumulated deficit of
approximately  $32,832,000. The accompanying condensed  financial
statements have been prepared assuming the Company will  continue
as a going concern.  The Company's ability to continue as a going
concern  is  dependent  upon performing profitably  or  obtaining
further  financing.   On March 25, 1997,  the  Company  signed  a
definitive agreement to sell its dental assets to Lares Research.
Consideration for the sale will be $4,000,000 in cash at  closing
and  $1,500,000 in an interest bearing promissory note, with  two
installments  due  three and four years, respectively,  from  the
date  of closing.  Should the sale of the dental assets  not   be
successfully  completed, the Company may need to seek  additional
debt  or  equity financing.  There can be no assurance that  such
financing,  if  necessary,  will  be  available,  in  which  case
management  may  need  to  curtail  or  suspend  certain  or  all
operations.

2.   Net Loss Per Share

   Net  loss per share for the three months ended March 31,  1997
and  1996  is based solely on weighted average shares  of  common
stock  outstanding  during the period.  Common equivalent  shares
have not been considered in the computation since their inclusion
would have an antidilutive effect.

   In  February  1997, the Financial Accounting  Standards  Board
issued  Statement No. 128, Earnings per Share, which is  required
to  be  adopted on December 31, 1997.  At that time, the  Company
will  be  required to change the method currently used to compute
earnings per share and restate all prior periods.  Under the  new
requirements  for  calculating basic  earnings  per  share,   the
dilutive  effect  of  stock options will not  be  included.   The
computed basic earnings per share will not be  different from the
primary earnings per share for the quarters ended March 31,  1997
and March 31, 1996.

3.   Revenue Recognition

   Revenues are recognized at time of shipment.  A provision  for
the  estimated future cost of warranty is made at the time a sale
is recorded.

                                4
<PAGE>


4.   Inventories

   Inventories  are  stated  at  the  lower  of  cost  (first-in,
first-out) or market and consisted of the following on the  dates
indicated:

                           March 31,      December
                              1997        31, 1996
                               (In thousands)

Raw materials               $1,327         $1,180  

Work-in-rocess                 401            299    

Finished goods                 497            656    
                            ______         ______

                            $2,225         $2,135  
                            ======         ======

5.   Income Taxes

   Due to the Company's losses from operations, all deferred  tax
assets,  which  primarily result from net  operating  loss  carry
forwards,  have been offset in full by a valuation  allowance  in
accordance with SFAS No. 109.

6.   Issuance of Redeemable Convertible Notes

   In February and March 1997, the Company completed a series  of
private placements (collectively, the "1997 Notes Placement")  of
5% redeemable convertible notes due 1999 (convertible into common
stock)  (the "Notes") and warrants to purchase common stock  (the
"Warrants").  The total face amount of the Notes is approximately
$4.1  million,  and  net proceeds aggregated  approximately  $3.7
million.  In  accordance  with  recent  Securities  and  Exchange
Commission Division of Corporation Finance guidance, the  Company
has  recorded a premium of approximately $769,000 associated with
the  conversion  feature  of  the Notes  as  additional  interest
associated with the Notes and paid-in-capital.  Because the Notes
are  immediately convertible at the holders' option,  the  entire
amount has been recorded as interest expense upon issuance of the
Notes.   The Company has recorded the Notes net of debt  offering
costs of approximately $358,000 and the value associated with the
Warrants  of  approximately $256,000, which will be amortized  as
interest expense over the period that the Notes are outstanding.

                                5
<PAGE>


                           Signatures

     Pursuant to the requirements of the Securities Exchange  Act
of  1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
     
     
                            SUNRISE TECHNOLOGIES INTERNATIONAL, INC.
 


Date:  June 10, 1997        By:  /s/ David W. Light
                               David W. Light
                               Chairman  of the Board and  Chief
                               Executive Officer


Date:  June 10, 1997        By:  /s/ Clara R. Munley
                               Clara R. Munley
                               Vice President, Finance and Chief
                               Financial Officer
                               (Principal Financial Officer)




                                6



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission